2019-0611 TRIM 5 alpha Restricts Flavivirus Replication by Targeting the Viral Protease for Proteasomal Degradation
暂无分享,去创建一个
Fadila | J. Luban | S. Sawyer | Kyusik Q Kim | R. Taylor | R. Ireland | Rebecca M. Broeckel | K. McNally | Abhilash I. Chiramel | S. Robertson | Gail L. Sturdevant | Nicholas R Meyerson | V. Hirsch | V. Nair | C. Bosio | N. R. Meyerson | Brian H. Youseff | Kirk J. Lubick | Vanessa R. Montoya | Omayra Méndez-Solís | Bouamr
[1] J. Luban,et al. Cyclophilin A protects HIV-1 from restriction by human TRIM5α , 2019, Nature Microbiology.
[2] L. James,et al. Trivalent RING Assembly on Retroviral Capsids Activates TRIM5 Ubiquitination and Innate Immune Signaling , 2018, Cell host & microbe.
[3] C. Tremblay,et al. HIV-1 capsids from B27/B57+ elite controllers escape Mx2 but are targeted by TRIM5α, leading to the induction of an antiviral state , 2018, PLoS pathogens.
[4] C. Broeckling,et al. Unique Francisella Phosphatidylethanolamine Acts as a Potent Anti-Inflammatory Lipid , 2018, Journal of Innate Immunity.
[5] Kristofor J. Webb,et al. Dengue viruses cleave STING in humans but not in nonhuman primates, their presumed natural reservoir , 2018, eLife.
[6] J. Moss,et al. TRIM23 mediates virus-induced autophagy via activation of TBK1 , 2017, Nature Microbiology.
[7] P. Nuttall,et al. Tick-Borne Viruses and Biological Processes at the Tick-Host-Virus Interface , 2017, Front. Cell. Infect. Microbiol..
[8] R. Mohana-Borges,et al. Systems Biology Reveals NS4B-Cyclophilin A Interaction: A New Target to Inhibit YFV Replication. , 2017, Journal of proteome research.
[9] S. Weaver,et al. Flavivirus transmission focusing on Zika. , 2017, Current opinion in virology.
[10] N. Kootstra,et al. Receptor usage dictates HIV-1 restriction by human TRIM5α in dendritic cell subsets , 2016, Nature.
[11] H. Ebihara,et al. Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga. , 2016, The Journal of infectious diseases.
[12] T. Pierson,et al. A CRISPR screen defines a signal peptide processing pathway required by flaviviruses , 2016, Nature.
[13] A. Gamarnik,et al. A Proline-Rich N-Terminal Region of the Dengue Virus NS3 Is Crucial for Infectious Particle Production , 2016, Journal of Virology.
[14] E. Campbell,et al. TRIM5α-Mediated Ubiquitin Chain Conjugation Is Required for Inhibition of HIV-1 Reverse Transcription and Capsid Destabilization , 2015, Journal of Virology.
[15] L. Berthoux,et al. Restriction Factors in HIV-1 Disease Progression. , 2015, Current HIV research.
[16] P. Uchil,et al. TRIM5 Retroviral Restriction Activity Correlates with the Ability To Induce Innate Immune Signaling , 2015, Journal of Virology.
[17] P. Autissier,et al. Evolutionary and Functional Analysis of Old World Primate TRIM5 Reveals the Ancient Emergence of Primate Lentiviruses and Convergent Evolution Targeting a Conserved Capsid Interface , 2015, PLoS pathogens.
[18] Dahai Luo,et al. The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development. , 2015, Antiviral research.
[19] V. Deretic,et al. TRIM proteins regulate autophagy: TRIM5 is a selective autophagy receptor mediating HIV-1 restriction , 2014, Autophagy.
[20] F. Kirchhoff,et al. TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. , 2014, Developmental cell.
[21] A. García-Sastre,et al. TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity. , 2014, Journal of molecular biology.
[22] Fan Wu,et al. TRIM5 alpha Drives SIVsmm Evolution in Rhesus Macaques , 2013, PLoS pathogens.
[23] S. Kutluay,et al. Fates of Retroviral Core Components during Unrestricted and TRIM5-Restricted Infection , 2013, PLoS pathogens.
[24] S. Aguirre,et al. DENV Inhibits Type I IFN Production in Infected Cells by Cleaving Human STING , 2012, PLoS pathogens.
[25] P. Gething,et al. Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus , 2012, PLoS neglected tropical diseases.
[26] Yi-Ling Lin,et al. Dengue Virus Targets the Adaptor Protein MITA to Subvert Host Innate Immunity , 2012, PLoS pathogens.
[27] J. Luban. TRIM5 and the Regulation of HIV-1 Infectivity , 2012, Molecular biology international.
[28] Kyudong Han,et al. Identification of a Genomic Reservoir for New TRIM Genes in Primate Genomes , 2011, PLoS genetics.
[29] M. Bloom,et al. TRIM79α, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase. , 2011, Cell host & microbe.
[30] Andrea Cimarelli,et al. A simple, versatile and efficient method to genetically modify human monocyte-derived dendritic cells with HIV-1–derived lentiviral vectors , 2011, Nature Protocols.
[31] Jeremy Luban,et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice , 2011, Nature.
[32] J. Sodroski,et al. Hexagonal assembly of a restricting TRIM5α protein , 2010, Proceedings of the National Academy of Sciences.
[33] Adolfo García-Sastre,et al. Viral tricks to grid-lock the type I interferon system , 2010, Current Opinion in Microbiology.
[34] S. Vasudevan,et al. Flexibility between the Protease and Helicase Domains of the Dengue Virus NS3 Protein Conferred by the Linker Region and Its Functional Implications , 2010, The Journal of Biological Chemistry.
[35] J. Luban,et al. p62/Sequestosome-1 Associates with and Sustains the Expression of Retroviral Restriction Factor TRIM5α , 2010, Journal of Virology.
[36] A. Barrett,et al. The NS5 Protein of the Virulent West Nile Virus NY99 Strain Is a Potent Antagonist of Type I Interferon-Mediated JAK-STAT Signaling , 2010, Journal of Virology.
[37] R. Bartenschlager,et al. Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics , 2009, PLoS pathogens.
[38] P. Shi,et al. Cyclosporine Inhibits Flavivirus Replication through Blocking the Interaction between Host Cyclophilins and Viral NS5 Protein , 2009, Antimicrobial Agents and Chemotherapy.
[39] M. Emerman,et al. An expanded clade of rodent Trim5 genes. , 2009, Virology.
[40] Matthew H. Stremlau. Why Old World Monkeys Are Resistant to HIV-1 , 2007, Science.
[41] P. Bieniasz,et al. Generation of Simian-Tropic HIV-1 by Restriction Factor Evasion , 2006, Science.
[42] D. Pérez-Caballero,et al. Antiretroviral potential of human tripartite motif-5 and related proteins. , 2006, Virology.
[43] J. Luban. Cyclophilin A, TRIM5, and Resistance to Human Immunodeficiency Virus Type 1 Infection , 2006, Journal of Virology.
[44] J. Sodroski,et al. Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. , 2006, Virology.
[45] Joseph Sodroski,et al. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[46] R. Doms,et al. West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection , 2006, Journal of Virology.
[47] M. Bloom,et al. Inhibition of Interferon-Stimulated JAK-STAT Signaling by a Tick-Borne Flavivirus and Identification of NS5 as an Interferon Antagonist , 2005, Journal of Virology.
[48] Michael Emerman,et al. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[49] J. Luban,et al. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1 , 2004, Nature.
[50] C. M. Owens,et al. The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys , 2004, Nature.
[51] P. Bieniasz,et al. Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[52] J. Mackenzie,et al. Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures , 1997, Journal of virology.
[53] W. Sundquist,et al. Crystal Structure of Human Cyclophilin A Bound to the Amino-Terminal Domain of HIV-1 Capsid , 1996, Cell.
[54] N. Mechti,et al. Molecular Cloning of a New Interferon-induced Factor That Represses Human Immunodeficiency Virus Type 1 Long Terminal Repeat Expression (*) , 1995, The Journal of Biological Chemistry.
[55] Jeremy Luban,et al. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B , 1993, Cell.
[56] E. G. Westaway,et al. Replication strategy of Kunjin virus: evidence for recycling role of replicative form RNA as template in semiconservative and asymmetric replication. , 1985, Virology.
[57] P. Simmonds. The origin of hepatitis C virus. , 2013, Current topics in microbiology and immunology.
[58] Charles M. Rice,et al. Flaviviridae :T he Viruses and Their Replication , 2007 .
[59] M. Emerman,et al. Restriction of an extinct retrovirus by the human TRIM5alpha antiviral protein. , 2007, Science.